GENE EXPRESSION MARKERS OF ONCOLYTIC VIRUS SENSITIVITY

  • US 20120004119A1
  • Filed: 06/29/2011
  • Published: 01/05/2012
  • Est. Priority Date: 06/30/2010
  • Status: Abandoned Application
First Claim
Patent Images

1. A method, comprising:

  • determining an expression level for each of a plurality of genes in a tumor sample obtained from a patient;

    calculating a total predictor score based on the expression levels for each of the plurality of genes; and

    predicting, if the total predictor score satisfies a first predictor score threshold, that an oncolytic virus treatment for the tumor would have efficacy, and if the total predictor score satisfies a second predictor score threshold, that the oncolytic virus treatment for the tumor would lack efficacy.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×